Beijing Anzhen Hospital
Clinical trials sponsored by Beijing Anzhen Hospital, explained in plain language.
-
Simple IV fluids may shield kidneys during new heart ablation technique
Disease control OngoingThis study tests whether giving extra fluids (saline) through an IV during and after a heart procedure called pulsed field ablation can prevent acute kidney injury. The procedure is used to treat atrial fibrillation, a common heart rhythm problem, but can sometimes harm the kidne…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
DNA-Guided heart therapy could prevent thousands of heart attacks
Disease control OngoingThis study looked at whether using a person's genetic information to choose their blood thinner medication after getting a heart stent can reduce the risk of heart attacks, strokes, and death. About 4,000 people with heart disease were given either clopidogrel or ticagrelor based…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can we predict which heart blockages will worsen after stenting?
Knowledge-focused OngoingThis observational study looks at why some untreated coronary artery blockages get worse over time in people who have already had a stent or balloon procedure for heart disease. Researchers will follow 1,400 adults aged 18-80 who are scheduled for a repeat angiogram, tracking the…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
AI model aims to predict heart risks after hip surgery in seniors
Knowledge-focused OngoingThis study develops and tests an artificial intelligence-based tool to predict major heart complications—such as heart attack, heart failure, or dangerous heart rhythms—in adults aged 60 and older after hip fracture surgery. Researchers will analyze data from 600 patients across …
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
AI could help heart surgery patients get the right Anti-Inflammatory drug
Knowledge-focused OngoingThis study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
AI could revolutionize heart attack care, new study hopes
Knowledge-focused OngoingThis study is testing a new AI-powered decision support system designed to help doctors diagnose and treat acute myocardial infarction (heart attack) more quickly and effectively. The system aims to address common delays in care, such as slow diagnosis in clinics and low complian…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC